Exane Derivatives Viatris Inc Transaction History

Exane Derivatives

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 12, 2022	SELL	$9.95 - $12.27 $514,832 - $634,874	-51,742 Closed	0 $0
Q1 2022 Apr 22, 2022	BUY	$9.81 - $15.4 $507,589 - $796,826	51,742 New	51,742 $562,000
Q4 2021 Jan 28, 2022	SELL	$12.09 - $14.68 $732,472 - $889,387	-60,585 Closed	0 $0
Q3 2021 Oct 26, 2021	BUY	$13.25 - $15.13 $795,715 - $908,617	60,054 Added 11309.6%	60,585 $820,000
Q2 2021 Jul 28, 2021	SELL	$12.97 - $16.15 $16,186 - $20,155	-1,248 Reduced 70.15%	531 $7,000
Q1 2021 Apr 30, 2021	BUY	$13.59 - $18.54 $17,857 - $24,361	1,314 Added 282.58%	1,779 $24,000
Q4 2020 Jan 27, 2021	BUY	$14.3 - $18.74 $6,649 - $8,714	465 New	465 $8,000

1,102

933M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Exane Derivatives, based on Form 13F filings with the SEC.

Stay updated on Exane Derivatives with notifications on news.